An introduction to the HOVON-141 trial in patients with CLL
Is double autologous transplantation in multiple myeloma superior in the age of new agents?
How the treatment of ALL is changing
The goals and work of the European Research Initiative on CLL (ERIC)
Topics in multiple myeloma discussed at ASCO 2016